Dr. Airewele is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6701 Fannin
Houston, TX 77030Phone+1 832-822-4242Fax+1 832-825-4362
Education & Training
- Baylor College of MedicineFellowship, Pediatric Hematology/Oncology, 1995 - 1998
- Rutgers Health/Newark Beth Israel Medical CenterResidency, Pediatrics, 1991 - 1995
- University of Benin Faculty of MedicineClass of 1986
Certifications & Licensure
- TX State Medical License 1999 - 2026
- NJ State Medical License 1994 - 2003
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- A Phase II Trial of Regadenoson in Sickle Cell Anemia Start of enrollment: 2013 Jul 01
Publications & Presentations
PubMed
- 26 citationsDetermining the longitudinal validity and meaningful differences in HRQL of the PedsQL™ Sickle Cell Disease ModuleJulie A. Panepinto, J. Paul Scott, Oluwakemi Badaki-Makun, Deepika S. Darbari, Corrie E. Chumpitazi
Health and Quality of Life Outcomes. 2017-06-12 - 47 citationsA multicenter randomized controlled trial of intravenous magnesium for sickle cell pain crisis in childrenDavid C. Brousseau, J. Paul Scott, Oluwakemi Badaki-Makun, Deepika S. Darbari, Corrie E. Chumpitazi
Blood. 2014-12-06 - 417 citationsMinimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trialJeffrey E. Rubnitz, Hiroto Inaba, Gary V. Dahl, Raul C. Ribeiro, W. Paul Bowman
The Lancet. Oncology. 2010-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: